Modified Membrane-Spanning Proteins for GPCR Stability and Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The low expression, homogeneity, stability, and high conformational flexibility of G Protein Coupled Receptors (GPCRs) pose significant challenges for drug discovery and development, limiting the effectiveness of protein-based approaches such as small molecule screening and antibody discovery.
Innovation Solution
A method involving combinatorial amino acid replacements in multiple positions of membrane-spanning proteins, particularly GPCRs, to generate stabilized receptors with improved expression, stability, homogeneity, and conformational selectivity, using a polynucleotide library and selective pressure agents to identify modified proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If GPCRs are used for drug discovery, then therapeutic opportunities are expanded, but protein expression and stability are insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying amino acid residues at specific positions (transmembrane domains, intracellular loops, extracellular domains) to alter protein stability parameters. Combinatorial mutagenesis generates libraries of variants with different stability characteristics, allowing selection of optimized GPCR variants for drug discovery applications.
Solution Approach 2:
The patent implements local quality by targeting specific regions of the GPCR protein for modification rather than uniform changes. Different amino acid positions are selectively mutated based on their functional importance - transmembrane domains for stability, intracellular loops for signaling, extracellular domains for ligand binding - thereby maintaining local functional properties while improving overall protein reliability.
2Manufacturing precision
If GPCRs are removed from cellular environment for structural determination, then structural analysis is enabled, but conformational flexibility increases
Solution Approach 1:
The patent uses parameter changes to stabilize GPCR conformations by modifying amino acid residues that influence protein folding and conformational dynamics. These mutations reduce unwanted conformational flexibility while preserving the ability to adopt functionally relevant states, enabling high-resolution structural determination.
Solution Approach 2:
The patent applies preliminary action by pre-stabilizing GPCR conformations through combinatorial mutagenesis before structural determination experiments. The modified proteins are prepared in advance with enhanced stability and reduced conformational heterogeneity, facilitating successful crystallization or cryo-EM analysis.
3Productivity
If small molecule screening is performed, then drug discovery is enabled, but protein homogeneity is insufficient
Solution Approach 1:
The patent implements parameter changes by modifying GPCR sequences to improve expression levels and homogeneity. Combinatorial mutagenesis at specific positions generates variants with enhanced solubility, reduced aggregation, and improved folding, resulting in more homogeneous protein populations for screening applications.
4Adaptability or versatility
If antibody discovery is pursued, then biologics development is enabled, but protein antigenicity is limited
Solution Approach 1:
The patent applies local quality by selectively modifying extracellular domains and epitopic regions of GPCRs to enhance antigenicity. These localized changes improve antibody recognition and binding without disrupting the overall protein structure or function, facilitating more effective antibody discovery campaigns.
Data Source
AI summary
In accordance with the present invention, there are provided functionally modulated tool receptors which are useful for drug discovery and development. In certain aspects and embodiments as described herein, a sophisticated and powerful approach has been designed that allows the rapid development of enhanced receptors, while simultaneously exploring millions of possibilities for improved properties with respect to such properties as protein expression, homogeneity, stabilization, conformational and activation pathway selectivity, antigenicity, immunogenicity, and the like. Indeed, the new methodology described herein represents a breakthrough by leveraging a full range of combinatorial amino acid replacements, in multiple positions simultaneously, in order to generate modified membrane-spanning proteins.